The study supports risk-based regulatory approaches, emphasizing realistic exposure scenarios for PFAS in textiles.

The GC–MS dataset was integrated with the sensory data using a series of exploratory and predictive multivariate statistical ...

Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...